Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:1-DeoxyCer 18:0;O/22:0)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST000916 AN001495 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma Blood Human Fatty liver disease LIPID MAPS nM
ST000917 AN001501 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine Urine Human Fatty liver disease LIPID MAPS nM
ST002339 AN003822 Myriocin rescue of serine-associated hepatic lipid diversity Liver Mouse Salk Institute for Biological Studies normalized ion count/mg protein
ST002340 AN003823 Serine supplementation and hepatic and skin sphingolipid diversity Liver Mouse Salk Institute for Biological Studies normalized ion count/mg protein
ST002340 AN003823 Serine supplementation and hepatic and skin sphingolipid diversity Skin Mouse Salk Institute for Biological Studies normalized ion count/mg protein
ST002343 AN003827 The impact of myriocin and dietary serine restriction on paw skin sphingolipid diversity Skin Mouse Salk Institute for Biological Studies normalized ion count/mg protein
ST002344 AN003828 The impact of dietary serine/glycine restriction and myriocin treatment on hepatic sphingolipid diversity during prolonged high fat diet feeding. Liver Mouse Salk Institute for Biological Studies normalized ion count/mg protein
ST001063 AN001740 Lipidomics analysis for aged mice organs Adipose tissue Mouse Takeda Pharmaceutical Company Limited Peak area
ST001063 AN001740 Lipidomics analysis for aged mice organs Brain Mouse Takeda Pharmaceutical Company Limited Peak area
ST001063 AN001740 Lipidomics analysis for aged mice organs Liver Mouse Takeda Pharmaceutical Company Limited Peak area
ST001063 AN001740 Lipidomics analysis for aged mice organs Muscle Mouse Takeda Pharmaceutical Company Limited Peak area
ST001065 AN001743 Lipidomics analysis for aged mice brain cortex (part-II) Adipose tissue Mouse Takeda Pharmaceutical Company Limited Peak area
ST001065 AN001743 Lipidomics analysis for aged mice brain cortex (part-II) Brain Mouse Takeda Pharmaceutical Company Limited Peak area
ST001065 AN001743 Lipidomics analysis for aged mice brain cortex (part-II) Liver Mouse Takeda Pharmaceutical Company Limited Peak area
ST001065 AN001743 Lipidomics analysis for aged mice brain cortex (part-II) Muscle Mouse Takeda Pharmaceutical Company Limited Peak area
ST001066 AN001745 Lipidomics analysis for aged mice liver (part-III) Adipose tissue Mouse Takeda Pharmaceutical Company Limited Peak area
ST001066 AN001745 Lipidomics analysis for aged mice liver (part-III) Brain Mouse Takeda Pharmaceutical Company Limited Peak area
ST001066 AN001745 Lipidomics analysis for aged mice liver (part-III) Liver Mouse Takeda Pharmaceutical Company Limited Peak area
ST001066 AN001745 Lipidomics analysis for aged mice liver (part-III) Muscle Mouse Takeda Pharmaceutical Company Limited Peak area
ST001067 AN001747 Lipidomics analysis for aged mice femoral muscle (part - IV) Adipose tissue Mouse Takeda Pharmaceutical Company Limited Peak area
ST001067 AN001747 Lipidomics analysis for aged mice femoral muscle (part - IV) Brain Mouse Takeda Pharmaceutical Company Limited Peak area
ST001067 AN001747 Lipidomics analysis for aged mice femoral muscle (part - IV) Liver Mouse Takeda Pharmaceutical Company Limited Peak area
ST001067 AN001747 Lipidomics analysis for aged mice femoral muscle (part - IV) Muscle Mouse Takeda Pharmaceutical Company Limited Peak area
ST002284 AN003732 Genetically defined human GBM organoids reveal principles of GBM development and actionable targets Cultured cells Human Cancer DKFZ peak intensity
ST000915 AN001489 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS pmol/mg
  logo